AIA
GMAB icon

AIMZ Investment Advisors’s Genmab GMAB Stock Holding History

AIMZ Investment Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.42M Hold
160,910
– – 1.22% 24
2026
Q1 		$4.32M Sell
160,910
-2,400
-1% -$71.9K 1.33% 21
2025
Q4 		$5.03M Sell
163,310
-1,200
-0.7% -$37.4K 1.44% 23
2025
Q3 		$5.05M Sell
164,510
-1,370
-0.8% -$33.4K 1.58% 18
2025
Q2 		$3.43M Sell
165,880
-1,900
-1% -$39K 1.15% 29
2025
Q1 		$3.29M Sell
167,780
-1,125
-0.7% -$23.6K 1.15% 31
2024
Q4 		$3.53M Buy
+168,905
New +$3.71M 1.22% 26

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

AIMZ Investment Advisors's GMAB Position: Q2 2026 in Review

AIMZ Investment Advisors held its Genmab (GMAB) position steady in Q2 2026 at 160,910 shares worth $4.42M. The position accounts for 1.22% of the portfolio, ranked #24.

AIMZ Investment Advisors first reported a position in GMAB in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.05M in Q3 2025. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • AIMZ Investment Advisors held 160,910 shares of Genmab worth $4.42M as of Q2 2026.
  • AIMZ Investment Advisors left its Genmab share count unchanged in Q2 2026.
  • Genmab made up 1.22% of AIMZ Investment Advisors's portfolio in Q2 2026, its #24 holding.
  • AIMZ Investment Advisors first reported a position in Genmab in Q4 2024 and has held it in 7 quarters since.
  • AIMZ Investment Advisors's Genmab position peaked at $5.05M in Q3 2025.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on AIMZ Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.